A long-term Finnish study suggests severe gingivitis and periodontitis may increase both the risk of developing a cerebral artery aneurysm and the likelihood that it will rupture. Dental caries, however, was not linked to aneurysm risk, placing the…
Read More...
Pink, Blue, and Biofilm: Test Your Disclosing Solution Know-How
How many questions can you get right? Test your knowledge!
When Untreated Tooth Decay Turns Deadly
A fatal case of sepsis linked to untreated dental caries underscores how oral disease can rapidly escalate into life-threatening…
Speak Out Against Expanding Anesthesia to Dental Assistants by December 18!
A California pilot program proposing to allow expanded function dental assistants to administer local anesthesia threatens to blur…
California’s System of Providing Dental Care Is in Crisis
New reporting from the San Francisco Standard reveals a worsening dental hygienist shortage in California that is reshaping both…
Weekly Popular
Personal Finance
More Top Stories
Of the Lives Lost Due to COVID-19 Since June, Many Could Have Been Saved With Vaccination
An analysis by the Kaiser Family Foundation has found that at least 90,000 deaths due to COVID-19 since June could have been saved if these Americans had been vaccinated. Fifty percent of these deaths happened in September. The brief also…
With COVID-19 Numbers Declining, Concern Shifts to Possible ‘Twindemic’
As the world grappled with the global pandemic last winter, one bright spot was the virtually nonexistent flu season. Well, some public health experts warn that not only will COVID-19 carry on through this winter, but we may face a severe…
Children in Clinical Study Show Reduction of Tooth Decay After Treatment With Vivos Guides
Vivos Therapeutics, Inc., a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive…
More COVID-19 Booster Shots to Come from Moderna and J&J
COVID-19 vaccine manufacturers Moderna and Johnson & Johnson (J&J) submitted data demonstrating the efficacy of their COVID-19 booster shots among those ages 18 and older to the United States Food and Drug Administration (FDA). The…
Combatting the COVID-19 Infodemic
As if dealing with COVID-19 over the past 22 months hasn’t been enough, the pandemic also caused an “infodemic”—when media sources disseminate incorrect information about a subject. In this case, all sorts of false information spread…
More Than a Third of Those Who Recover from COVID-19 Experience Long-Term Effects
An Oxford University study found that 37% of those who have recovered from COVID-19 illness still experience at least one side effect 3 months to 6 months later. The most commonly reported side effects were respiratory issues, malaise,…
COVID-19 Vaccination Rates in the US Continue to Increase
More Americans are rolling up their sleeves to get vaccinated against COVID-19 as the pandemic wears on across the globe. Today, approximately 72% of US adults are currently immunized, up from 68% in July. The biggest gains were found among…
COVID-19 Severity and Poor Oral Health Are Linked in Those With Heart Disease
Individuals with cardiovascular disease experienced greater severity of COVID-19 illness and longer recovery times in the presence of poor oral health, according to new research out of Egypt. In the study of 86 patients with cardiovascular…
MouthWatch Launches HD Intraoral Camera
MouthWatch, a leader in innovative teledentistry solutions, digital case presentation tools and intraoral cameras, will debut its MouthWatch Plus+ HD intraoral camera during SmileCon 2021 in Las Vegas. With a launch special price of $999…
Pfizer Requests EUA to Administer its COVID-19 Vaccine to Kids
Pfizer has applied for Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccination to children ages 5 to 11. The FDA has already granted full approval to the Pfizer…
Market Media
- Advertisement -
